CD4 and tuberculosis: NLRC3 prevents the activation, proliferation, and differentiation of CD4+T cells by inhibiting the NF-κB and ERK/MEK signaling pathways, thereby attenuating the body’s anti-tuberculosis immunity, and the inhibition of CD4+T cells in turn suppresses the innate immune responses and further promotes M. tuberculosis survival (38).